Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken(University of Antwerp), Ricardo Hitt(Hospital Universitario Severo Ochoa)
Cited by 3,704
Related Papers
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
|Journal of Clinical Oncology|2005|491
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
|Journal of Clinical Oncology|2005|454
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
|Annals of Oncology|2013|351